I was thinking over the weekend if you were to invest in the ideal company in this market to make a lot of money what would it be. Well I think it would have to be something along the lines of;
- in the biotec sector as there always seems to be a higher premium for PE ratios,
- need to be in at the start of a up swing,
- drag management across from some very high profile Biotec companies to run it,
- cutting edge technology that could be worth hundred's of millions but not cost much,
-to have a international patent already in place for some of it
- to be in the path of a company that is about to get FDA for something similar,
- timing, to be in a market where traders can smell money
- to be first to a new market that is massive, namely home Care, medical diagnostics
-to have a lot of research already up and running and product ready to commercialise
- to have commercial partnerships ready to potentially come in
- to list at the very minimum ASX new listing price of 2 cents to get max leverage
-to have access to the best resources for research like University's and even then to be supported by a University known for it's technology prowess.
- a company with a tight capital structure - but liquid enough to buy big and trade.
-management committed to news flow and keeping the market regularly informed.
-ability technically for this to develop momentum of accumulation with only buying taking place and investors reluctant to sell due to approaching commercialisation
I was thinking something along these lines - if I could get some stock I'd do pretty well.
- Forums
- ASX - By Stock
- MNQ
- News flow
News flow, page-3
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online